Spinal meningioma

Summary

Spinal meningioma (MONDO:0001275) is a disease. A subtype of intraspinal meningioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	spinal meningioma
Mondo ID	MONDO:0001275
DOID	DOID:1138
NCIT	C6935
SNOMED CT	189167009
UMLS	C0347515
MedGen	87576
GARD	0010264
Anatomy (UBERON)	UBERON:0002240
Is cancer (heuristic)	no

Also known as: meningioma (disease) of spinal cord · meningioma of spinal cord · meningioma of the spinal cord · meningioma, spine · spinal cord meningioma · spinal cord meningioma (disease)

Disease family

This is a subtype of intraspinal meningioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › tumor of meninges › meningioma › intraspinal meningioma › spinal meningioma

Related subtypes (6): epidural spinal canal meningioma, thoracic spinal canal and spinal cord meningioma, lumbar spinal canal and spinal cord meningioma, multiple spinal canal and spinal cord meningioma, cervical spinal canal and spinal cord meningioma, sacral spinal canal and spinal cord meningioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.